Loading...

BGLC BIONEXUS GENE LAB CORP Capital Structure Changes 8-K Filing

BNXS

BGLC

BIONEXUS GENE LAB CORP

(BGLC)

2025 8-K

Show Summary

Summary

Shareholder Meeting

Strategic Partnership

Ethereum Strategy

Nasdaq Compliance

Delisting Notification

Director Resignations

Annual Meeting Results

Biogas Collaboration

Strategic Agreement

Expansion Plans

Co-Investment Announcement

Strategic Investment

Amendment of Service Contract

Management Changes

Resignation of CFO

Amendment - Disclosure of F...

Appointment of CEO

Resignation of CEO

Management Changes

Equity Offerings

External Links:

Bionexus Gene Lab Corp created and issued one share of Series Z Convertible Preferred Stock, which has 5 billion votes, to facilitate a Reverse Stock Split proposal at an upcoming shareholder meeting.

AI Assistant

BIONEXUS GENE LAB CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.